Jan Ferlak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jan Ferlak has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Weronika Guzenda
Pharmacy Practice and Pharmaceutical Care Division, Chair and Department of Pharmaceutical Technology, Poznan University of Medical Sciences, 3 Rokietnicka Street, 60-806 Poznan, Poland
2 shared publications Bartosz Chmielewski
Faculty of Health Sciences, State University of Applied Sciences in Konin, Konin, Poland
1 shared publication- Julia Liwarska
Doctoral School, Poznań University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland
1 shared publication - Laura Olsztyńska
Student’s Pharmaceutical Care Group, Pharmacy Practice Division, Department of Pharmaceutical Technology, Poznan University of Medical Sciences, 6 Grunwaldzka Street, 60-780 Poznan, Poland
1 shared publication Maciej Tomczak
Department of Psychology, Poznań University of Physical Education, Poznan, Poland
1 shared publication- Maciej Wilski
Department of Health and Rehabilitation Psychology, Poznań University of Physical Education, 61-871 Poznan, Poland
1 shared publication
Latest Publications
- Open Access
- 20 January 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 361
Orodispersible Films—Current State of the Art, Limitations, Advances and Future Perspectives
Orodispersible Films (ODFs) are drug delivery systems manufactured with a wide range of methods on a big scale or for customized medicines and small-scale pharmacy. Both ODFs and their fabrication methods have certain limitations. Many pharmaceutical companies and academic research centers across the world cooperate in order to cope with these issues and also to find new formulations for a wide array of APIs what could make their work profitable for them and beneficial for patients as well. The number of pending patent applications and granted patents with their innovative approaches makes the progress in the manufacturing of ODFs unquestionable. The number of commercially available ODFs is still growing. However, some of them were discontinued and are no longer available on the markets. This review aims to summarize currently marketed ODFs and those withdrawn from sale and also provides an insight into recently published studies concerning orodispersible films, emphasizing of utilized APIs. The work also highlights the attempts of scientific communities to overcome ODF’s manufacturing methods limitations.
- 20 January 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 361
Open AccessOrodispersible Films—Current State of the Art, Limitations, Advances and Future Perspectives
Orodispersible Films (ODFs) are drug delivery systems manufactured with a wide range of methods on a big scale or for customized medicines and small-scale pharmacy. Both ODFs and their fabrication methods have certain limitations. Many pharmaceutical companies and academic research centers across the world cooperate in order to cope with these issues and also to find new formulations for a wide array of APIs what could make their work profitable for them and beneficial for patients as well. The number of pending patent applications and granted patents with their innovative approaches makes the progress in the manufacturing of ODFs unquestionable. The number of commercially available ODFs is still growing. However, some of them were discontinued and are no longer available on the markets. This review aims to summarize currently marketed ODFs and those withdrawn from sale and also provides an insight into recently published studies concerning orodispersible films, emphasizing of utilized APIs. The work also highlights the attempts of scientific communities to overcome ODF’s manufacturing methods limitations.
- Open Access
- 16 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11713
Interdisciplinary Cooperation between Pharmacists and Nurses—Experiences and Expectations
Background: Getting to know the experience gained so far between professions such as pharmacists and nurses allows for introducing changes aimed at better cooperation, and that can improve the quality of patient care. The aim was to obtain the nurses’ opinions on the ongoing cooperation with pharmacists and to analyze the possibilities of cooperation between these groups. Methods: The survey was conducted from January to March 2021 among 124 nurses in Poland. The link to the electronic questionnaire was sent by e-mails sourced from online social groups for nurses. Before completing the questionnaire, each participant was informed about the anonymous research and the purpose of the data obtained. Results: In total, 80.6% of the respondents confirmed that the pharmacist is a reliable advisor in the field of general information about a drug and 60.9% in the field of clinical information about the drug, and 54.8% of the nurses agreed that a pharmacist should carry out such practices as measuring blood pressure or glucose in a community pharmacy, with 70.1% agreeing that a pharmacist should provide pharmaceutical care in a community pharmacy in the future and the most convinced of this were people with a master’s degree. Of the respondents, 74.1% indicated that pharmacist advice should be fully reimbursed by the National Health Fund or another insurance institution. Conclusions: The study showed that the nursing community appreciates the role of pharmacists and has a positive attitude towards cooperation with this professional group. What is more is that it indicates willingness for interdisciplinary cooperation.
- 16 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11713
Open AccessInterdisciplinary Cooperation between Pharmacists and Nurses—Experiences and Expectations
Background: Getting to know the experience gained so far between professions such as pharmacists and nurses allows for introducing changes aimed at better cooperation, and that can improve the quality of patient care. The aim was to obtain the nurses’ opinions on the ongoing cooperation with pharmacists and to analyze the possibilities of cooperation between these groups. Methods: The survey was conducted from January to March 2021 among 124 nurses in Poland. The link to the electronic questionnaire was sent by e-mails sourced from online social groups for nurses. Before completing the questionnaire, each participant was informed about the anonymous research and the purpose of the data obtained. Results: In total, 80.6% of the respondents confirmed that the pharmacist is a reliable advisor in the field of general information about a drug and 60.9% in the field of clinical information about the drug, and 54.8% of the nurses agreed that a pharmacist should carry out such practices as measuring blood pressure or glucose in a community pharmacy, with 70.1% agreeing that a pharmacist should provide pharmaceutical care in a community pharmacy in the future and the most convinced of this were people with a master’s degree. Of the respondents, 74.1% indicated that pharmacist advice should be fully reimbursed by the National Health Fund or another insurance institution. Conclusions: The study showed that the nursing community appreciates the role of pharmacists and has a positive attitude towards cooperation with this professional group. What is more is that it indicates willingness for interdisciplinary cooperation.
- Open Access
- 1 August 2021
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 53, 103027
Coping profiles in multiple sclerosis: Comparison of personal resources
- 1 August 2021
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 53, 103027
Open AccessCoping profiles in multiple sclerosis: Comparison of personal resources